CIM LLC’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $506K | Sell |
23,333
-2,511
| -10% | -$54.5K | 0.07% | 115 |
|
|
2025
Q1 | $627K | Sell |
25,844
-1,195
| -4% | -$29K | 0.09% | 105 |
|
|
2024
Q4 | $564K | Sell |
27,039
-28
| -0.1% | -$584 | 0.08% | 115 |
|
|
2024
Q3 | $538K | Sell |
27,067
-180
| -0.7% | -$3.58K | 0.08% | 112 |
|
|
2024
Q2 | $540K | Sell |
27,247
-104
| -0.4% | -$2.06K | 0.08% | 108 |
|
|
2024
Q1 | $436K | Buy |
27,351
+188
| +0.7% | +$3K | 0.07% | 111 |
|
|
2023
Q4 | $378K | Buy |
27,163
+2,250
| +9% | +$31.3K | 0.06% | 115 |
|
|
2023
Q3 | $291K | Buy |
24,913
+871
| +4% | +$10.2K | 0.06% | 122 |
|
|
2023
Q2 | $323K | Buy |
24,042
+1,286
| +6% | +$17.3K | 0.06% | 125 |
|
|
2023
Q1 | $377K | Sell |
22,756
-640
| -3% | -$10.6K | 0.07% | 113 |
|
|
2022
Q4 | $362K | Sell |
23,396
-923
| -4% | -$14.3K | 0.07% | 121 |
|
|
2022
Q3 | $340K | Buy |
+24,319
| New | +$340K | 0.07% | 124 |
|